Research and Funding

Blog post - enabling partnerships for Alzheimer's disease drug development

June 12, 2013


A new blog post reports on a recent NIA scientific meeting on Alzheimer's disease. More than 60 leaders from academia, government, foundations, and industry met in Bethesda to discuss partnerships and how they could lead to drugs for Alzheimer's treatment. Dr. Suzana Petanceska, an NIA Program Director, describes the new opportunities and connections sparked by the meeting: "We hope that these discussions will lead to new collaborations and ultimately new partnerships to accelerate Alzheimer's disease therapy development."

Read the full blog post: Enabling partnerships for Alzheimer's disease drug development - meeting report

Share this:
Email Twitter Linkedin Facebook